menu
    • menu

    Company profile for IVAX Pharmaceuticals Inc

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We’re Teva UK Limited, a leader in UK healthcare, supplying a wide range of medicines to the UK health service in a wide range of disease areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IVAX Pharmaceuticals IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4400 Biscayne Blvd, Miami, FL 33137
    Telephone
    Telephone
    +1 305-575-6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tevapharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Meet the Man Who Was Just Named Genentech's New CEO
    Meet the Man Who Was Just Named Genentech's New CEO

    16 Dec 2016

    // Mark Terry BIOSPACE

    http://www.biospace.com/News/meet-the-man-who-was-just-named-genentechs-new-ceo/442015/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    16 Dec 2016
    Share Share
    Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO
    Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

    05 Dec 2016

    // PHARMA FILE

    http://www.pharmafile.com/appointment/511793/xenetic-biosciences-promote-jeffrey-eisenberg-board-member-coo

    PHARMA FILE
    05 Dec 2016
    Share Share
    Chicago psychiatrist slapped with prison time in Teva kickbacks case
    Chicago psychiatrist slapped with prison time in Teva kickbacks case

    17 Mar 2016

    // Emily Wasserman FIERCE PHARMA

    http://www.fiercepharma.com/story/chicago-psychiatrist-slapped-prison-time-teva-kickbacks-case/2016-03-17

    Emily Wasserman FIERCE PHARMA
    17 Mar 2016
    Share Share
    Pediatric Exclusivity: Amazingly Powerful, Essentially Ironclad . . . and Often Overlooked
    Pediatric Exclusivity: Amazingly Powerful, Essentially Ironclad . . . and Often Overlooked

    07 Jul 2015

    // Kurt R. Karst FDA LAW BLOG

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/07/pediatric-exclusivity-amazingly-powerful-essentially-ironclad-and-often-overlooked.html

    Kurt R. Karst FDA LAW BLOG
    07 Jul 2015
    Share Share
    US drug company buys EirGen for $135m
    US drug company buys EirGen for $135m

    06 May 2015

    // John McManus THE IRISH TIMES

    http://www.irishtimes.com/business/health-pharma/us-drug-company-buys-eirgen-for-135m-1.2201150

    John McManus THE IRISH TIMES
    06 May 2015
    Share Share
    Ivax's (Tolterodine Tartrate 1Mg, 2Mg) Approved in USA for Overactive Bladder
    Ivax's (Tolterodine Tartrate 1Mg, 2Mg) Approved in USA for Overactive Bladder

    23 Feb 2015

    // Press Release FDA

    https://www.pharmacompass.com/pdf/news/n26.pdf

    Press Release FDA
    23 Feb 2015
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    BIO Partnering at JPM
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BIO Partnering at JPM
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-11-11

    IVAX Pharmaceuticals Inc

    City : Runcorn

    State :

    Country/Area : United Kingdom

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-11-11

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    BIO Partnering at JPM
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BIO Partnering at JPM
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-06-06

    IVAX Pharmaceuticals Inc

    City : Doral

    State : FL

    Country/Area : U.S.A

    Zip : 33178-2404

    District : FLA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2013-06-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    BIO Partnering at JPM
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BIO Partnering at JPM
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-11-06

    IVAX Pharmaceuticals Inc

    City : Runcorn

    State :

    Country/Area : United Kingdom

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-11-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    BIO Partnering at JPM
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BIO Partnering at JPM
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-11-19

    IVAX Pharmaceuticals Inc

    City : Runcorn

    State :

    Country/Area : United Kingdom

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-11-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    BIO Partnering at JPM
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BIO Partnering at JPM
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2010-01-26

    IVAX Pharmaceuticals Inc

    City : Doral

    State : FL

    Country/Area : U.S.A

    Zip : 33178-2404

    District : FLA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-01-26

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    BIO Partnering at JPM
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BIO Partnering at JPM
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-04-22

    IVAX Pharmaceuticals Inc

    City : Runcorn

    State :

    Country/Area : United Kingdom

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-04-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact IVAX Pharmaceuticals Inc and get a quotation

    IVAX Pharmaceuticals Inc is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Cabergoline bulk offered by IVAX Pharmaceuticals Inc

    Find a price of Mycophenolate Mofetil bulk offered by IVAX Pharmaceuticals Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search